Gabriela Lavezzari is Associate Partner at Opus Three and the Founder and Principal of Vertex Advisors, a business development and strategy consulting firm that specializes in creating sustainable growth for startup businesses and small-, to medium-sized companies through successful expansion.
She served most recently as SVP Business Development at Biocerna, a clinical laboratory diagnostics company with the unique mission of making personalized medicine available and affordable to patient and providers. While at Biocerna, Dr. Lavezzari led business development and corporate strategy and was able to develop and negotiate novel reimbursement models to bring Biocerna at the forefront of the healthcare debate with public and private payers and partners.
Prior to joining Biocerna, Dr. Lavezzari was a Research Director at the Duke-Robert J. Margolis Center for Health Policy where she led the development of new evidence-based policies to support the shift the current payment models for innovative medical products from fee-for-service (FFS) to value-based. Combining her experience working at PhRMA, the leading pharmaceutical trade association and Express Scripts (previously Medco Health Solutions), Dr. Lavezzari is uniquely positioned to understand the current gaps in the healthcare space and develop novel approaches to improve patient outcome while lowering overall healthcare costs.
Gabriela Lavezzari received her PhD in Biological Sciences from University of Milano (Italy), and has received her MBA from the New York Institute of Technology (NYIT, NY).